Yan Ming, Zhao Lei, Zheng Fang, Sun Xiaobo, Zhang Ying, Wang Chunhong
Center for Gene Diagnosis, Zhongnan Hospital of Wuhan University, Donghu Road 169, Wuhan, Hubei 430071, PR China.
Biochem Genet. 2007 Feb;45(1-2):1-9. doi: 10.1007/s10528-006-9043-0.
We investigated the relationships among the +1444C/T polymorphism in the C-reactive protein (CRP) gene and the concentration of CRP and the risk of coronary heart disease. Using polymerase chain reaction-restriction fragment length polymorphism, we analyzed the frequency distribution of genotypes and alleles of the +1444C/T polymorphism in samples from 128 patients with coronary heart disease (coronary stenosis more than 50%) and 119 unrelated normal individuals. The plasma levels of CRP and lipids in the subjects were also measured. The frequencies of the genotypes were CC 89.1%, CT 10.9%, and TT 0% in patients and CC 89.9%, CT 10.1%, and TT 0% in controls. The frequency of allele C was 94.5% in patients and 95.0% in controls, and allele T was 5.5% in patients and 5.1% in controls. The distribution of genotypes and alleles in the Chinese Han population was significantly different from that of the Caucasian population. There were no significant differences between frequencies of genotype and allele of controls and those of patients (P>0.05), but in controls the concentrations of CRP in the CC genotype subgroup were significantly higher than those in the CT genotype subgroup (P<0.05). This suggests that the +1444C/T variant in the CRP gene influences the basal CRP level in normal people. These findings imply that there may eventually be a need to establish genotype-specific risk thresholds of the CRP level.
我们研究了C反应蛋白(CRP)基因中+1444C/T多态性与CRP浓度及冠心病风险之间的关系。采用聚合酶链反应-限制性片段长度多态性方法,我们分析了128例冠心病患者(冠状动脉狭窄超过50%)和119名无亲缘关系的正常个体样本中+1444C/T多态性的基因型和等位基因频率分布。还测量了受试者血浆中CRP和血脂水平。患者中基因型CC的频率为89.1%,CT为10.9%,TT为0%;对照组中基因型CC的频率为89.9%,CT为10.1%,TT为0%。患者中等位基因C的频率为94.5%,对照组为95.0%;患者中等位基因T的频率为5.5%,对照组为5.1%。中国汉族人群的基因型和等位基因分布与白种人群有显著差异。对照组和患者的基因型和等位基因频率之间无显著差异(P>0.05),但在对照组中,CC基因型亚组的CRP浓度显著高于CT基因型亚组(P<0.05)。这表明CRP基因中的+1444C/T变异影响正常人的基础CRP水平。这些发现意味着最终可能需要建立基于基因型的CRP水平风险阈值。